FDA Commercial - Search News

FDA, Lead and baby food

FDA Limits Toxic Lead in Some Baby Foods

The Food and Drug Administration has set maximum levels for lead in baby foods like jarred fruits and vegetables, yogurts and dry cereal

CNN on MSN · 4h

FDA sets new lower levels for lead in baby food — critics say that’s not enough

For the first time, the US Food and Drug Administration has set a limit on the amount of lead that can be in baby foods, but critics say it’s too little, too late.

WRAL · 7h

FDA disappoints child advocates with its new limit on lead in baby food

For the first time in history, the US Food and Drug Administration has established guidance for levels of lead in processed baby foods that are sold on supermarket shelves and online. The agency’s action,

BioPharma Dive13h

5 FDA decisions to watch in the first quarter of 2025

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Cure Today2d

FDA Reviews NDA for Dordaviprone in Recurrent H3 K27M-Mutant Diffuse Glioma

Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...

JD Supra3d

FDA Announced Removal of Tirzepatide from the Drug Shortage List

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

11h

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025Cyprium is eligible to receive royalties and up to $129 ...

Yahoo Finance7d

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

“As we entered 2024, the Company had three primary goals in our quest to ensure we are ready for the successful commercial launch of LIBERTY in 2025: 1) complete FDA 510(k) submission ...

FiercePharma4d

Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results